nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Tolazoline—Phentermine—obesity	0.107	0.254	CrCrCtD
Naphazoline—Butenafine—Benzphetamine—obesity	0.104	0.248	CrCrCtD
Naphazoline—Tolazoline—Methamphetamine—obesity	0.0951	0.226	CrCrCtD
Naphazoline—ADRA1A—Phendimetrazine—obesity	0.0676	0.153	CbGbCtD
Naphazoline—ADRA2C—Methamphetamine—obesity	0.0648	0.147	CbGbCtD
Naphazoline—Naftifine—Benzphetamine—obesity	0.0624	0.148	CrCrCtD
Naphazoline—ADRA2B—Methamphetamine—obesity	0.0615	0.139	CbGbCtD
Naphazoline—ADRA2A—Benzphetamine—obesity	0.0535	0.121	CbGbCtD
Naphazoline—Antazoline—Benzphetamine—obesity	0.0518	0.123	CrCrCtD
Naphazoline—ADRA1A—Benzphetamine—obesity	0.0513	0.116	CbGbCtD
Naphazoline—ADRA2A—Phenylpropanolamine—obesity	0.051	0.116	CbGbCtD
Naphazoline—ADRA1A—Phenylpropanolamine—obesity	0.0489	0.111	CbGbCtD
Naphazoline—ADRA2A—Methamphetamine—obesity	0.0427	0.0969	CbGbCtD
Naphazoline—Mydriasis—Diethylpropion—obesity	0.00215	0.0381	CcSEcCtD
Naphazoline—Intraocular pressure increased—Sibutramine—obesity	0.00198	0.0351	CcSEcCtD
Naphazoline—Intraocular pressure increased—Bupropion—obesity	0.00173	0.0306	CcSEcCtD
Naphazoline—Sweating—Benzphetamine—obesity	0.00142	0.0251	CcSEcCtD
Naphazoline—Sweating—Phendimetrazine—obesity	0.00129	0.0229	CcSEcCtD
Naphazoline—Duloxetine—NPY1R—obesity	0.00128	0.458	CrCbGaD
Naphazoline—Drowsiness—Phenylpropanolamine—obesity	0.00115	0.0204	CcSEcCtD
Naphazoline—Intraocular pressure increased—Topiramate—obesity	0.0011	0.0195	CcSEcCtD
Naphazoline—Ocular hyperaemia—Topiramate—obesity	0.00103	0.0183	CcSEcCtD
Naphazoline—Endophthalmitis—Topiramate—obesity	0.00102	0.018	CcSEcCtD
Naphazoline—Vision blurred—Phendimetrazine—obesity	0.000993	0.0176	CcSEcCtD
Naphazoline—Drowsiness—Diethylpropion—obesity	0.000959	0.017	CcSEcCtD
Naphazoline—Mydriasis—Bupropion—obesity	0.000953	0.0169	CcSEcCtD
Naphazoline—Drowsiness—Cimetidine—obesity	0.000913	0.0162	CcSEcCtD
Naphazoline—Hyperhidrosis—Benzphetamine—obesity	0.000912	0.0161	CcSEcCtD
Naphazoline—Tension—Phenylpropanolamine—obesity	0.000883	0.0156	CcSEcCtD
Naphazoline—Nervousness—Phenylpropanolamine—obesity	0.000874	0.0155	CcSEcCtD
Naphazoline—Vision blurred—Phenylpropanolamine—obesity	0.000848	0.015	CcSEcCtD
Naphazoline—Tension—Phentermine—obesity	0.000845	0.015	CcSEcCtD
Naphazoline—Nervousness—Phentermine—obesity	0.000837	0.0148	CcSEcCtD
Naphazoline—Hyperhidrosis—Phendimetrazine—obesity	0.000831	0.0147	CcSEcCtD
Naphazoline—Lacrimation increased—Bupropion—obesity	0.000825	0.0146	CcSEcCtD
Naphazoline—Erythema—Diethylpropion—obesity	0.000749	0.0133	CcSEcCtD
Naphazoline—Hypertension—Phentermine—obesity	0.000744	0.0132	CcSEcCtD
Naphazoline—Tension—Diethylpropion—obesity	0.000735	0.013	CcSEcCtD
Naphazoline—Nervousness—Diethylpropion—obesity	0.000728	0.0129	CcSEcCtD
Naphazoline—Redness—Topiramate—obesity	0.000717	0.0127	CcSEcCtD
Naphazoline—Vision blurred—Diethylpropion—obesity	0.000706	0.0125	CcSEcCtD
Naphazoline—Eye pain—Sibutramine—obesity	0.000701	0.0124	CcSEcCtD
Naphazoline—NISCH—islet of Langerhans—obesity	0.000682	0.113	CbGeAlD
Naphazoline—Somnolence—Phenylpropanolamine—obesity	0.000653	0.0116	CcSEcCtD
Naphazoline—Dizziness—Methamphetamine—obesity	0.000647	0.0115	CcSEcCtD
Naphazoline—Discomfort—Diethylpropion—obesity	0.00063	0.0112	CcSEcCtD
Naphazoline—Dizziness—Benzphetamine—obesity	0.000624	0.011	CcSEcCtD
Naphazoline—Headache—Methamphetamine—obesity	0.000613	0.0109	CcSEcCtD
Naphazoline—Eye pain—Bupropion—obesity	0.000611	0.0108	CcSEcCtD
Naphazoline—Mydriasis—Topiramate—obesity	0.000607	0.0107	CcSEcCtD
Naphazoline—Hyperhidrosis—Diethylpropion—obesity	0.000591	0.0105	CcSEcCtD
Naphazoline—Headache—Benzphetamine—obesity	0.000591	0.0105	CcSEcCtD
Naphazoline—Dizziness—Phendimetrazine—obesity	0.000569	0.0101	CcSEcCtD
Naphazoline—Nausea—Benzphetamine—obesity	0.000561	0.00992	CcSEcCtD
Naphazoline—Somnolence—Diethylpropion—obesity	0.000544	0.00963	CcSEcCtD
Naphazoline—NISCH—adrenal cortex—obesity	0.000541	0.0897	CbGeAlD
Naphazoline—Headache—Phendimetrazine—obesity	0.000539	0.00954	CcSEcCtD
Naphazoline—Lacrimation increased—Topiramate—obesity	0.000525	0.0093	CcSEcCtD
Naphazoline—Somnolence—Cimetidine—obesity	0.000517	0.00916	CcSEcCtD
Naphazoline—Nausea—Phendimetrazine—obesity	0.000511	0.00904	CcSEcCtD
Naphazoline—ADRA1A—hindbrain—obesity	0.000506	0.0839	CbGeAlD
Naphazoline—Asthenia—Phentermine—obesity	0.000504	0.00893	CcSEcCtD
Naphazoline—Hyperglycaemia—Sibutramine—obesity	0.000493	0.00873	CcSEcCtD
Naphazoline—Dizziness—Phenylpropanolamine—obesity	0.000486	0.0086	CcSEcCtD
Naphazoline—Sweating—Sibutramine—obesity	0.000467	0.00827	CcSEcCtD
Naphazoline—Dizziness—Phentermine—obesity	0.000465	0.00823	CcSEcCtD
Naphazoline—Headache—Phentermine—obesity	0.00044	0.0078	CcSEcCtD
Naphazoline—NISCH—pituitary gland—obesity	0.000437	0.0724	CbGeAlD
Naphazoline—Nausea—Phenylpropanolamine—obesity	0.000436	0.00773	CcSEcCtD
Naphazoline—NISCH—adipose tissue—obesity	0.000435	0.0722	CbGeAlD
Naphazoline—Hyperglycaemia—Bupropion—obesity	0.00043	0.00761	CcSEcCtD
Naphazoline—Nausea—Phentermine—obesity	0.000418	0.00739	CcSEcCtD
Naphazoline—Asthenia—Cimetidine—obesity	0.000418	0.00739	CcSEcCtD
Naphazoline—Eye disorder—Sibutramine—obesity	0.000409	0.00724	CcSEcCtD
Naphazoline—Sweating—Bupropion—obesity	0.000407	0.00721	CcSEcCtD
Naphazoline—Dizziness—Diethylpropion—obesity	0.000404	0.00716	CcSEcCtD
Naphazoline—NISCH—adrenal gland—obesity	0.00039	0.0647	CbGeAlD
Naphazoline—Eye pain—Topiramate—obesity	0.000389	0.00689	CcSEcCtD
Naphazoline—Dizziness—Cimetidine—obesity	0.000385	0.00681	CcSEcCtD
Naphazoline—Headache—Diethylpropion—obesity	0.000383	0.00678	CcSEcCtD
Naphazoline—Tension—Sibutramine—obesity	0.000374	0.00662	CcSEcCtD
Naphazoline—Vision blurred—Orlistat—obesity	0.000371	0.00657	CcSEcCtD
Naphazoline—Nervousness—Sibutramine—obesity	0.00037	0.00655	CcSEcCtD
Naphazoline—Headache—Cimetidine—obesity	0.000365	0.00645	CcSEcCtD
Naphazoline—Nausea—Diethylpropion—obesity	0.000363	0.00643	CcSEcCtD
Naphazoline—Vision blurred—Sibutramine—obesity	0.000359	0.00636	CcSEcCtD
Naphazoline—Eye disorder—Bupropion—obesity	0.000357	0.00631	CcSEcCtD
Naphazoline—Nausea—Cimetidine—obesity	0.000346	0.00612	CcSEcCtD
Naphazoline—Discomfort—Orlistat—obesity	0.000331	0.00586	CcSEcCtD
Naphazoline—Hypertension—Sibutramine—obesity	0.000329	0.00582	CcSEcCtD
Naphazoline—Tension—Bupropion—obesity	0.000326	0.00577	CcSEcCtD
Naphazoline—Nervousness—Bupropion—obesity	0.000323	0.00571	CcSEcCtD
Naphazoline—Discomfort—Sibutramine—obesity	0.00032	0.00567	CcSEcCtD
Naphazoline—Terbinafine—CYP19A1—obesity	0.000318	0.114	CrCbGaD
Naphazoline—Vision blurred—Bupropion—obesity	0.000313	0.00554	CcSEcCtD
Naphazoline—Hyperhidrosis—Orlistat—obesity	0.000311	0.0055	CcSEcCtD
Naphazoline—NISCH—liver—obesity	0.000305	0.0506	CbGeAlD
Naphazoline—Hyperhidrosis—Sibutramine—obesity	0.000301	0.00532	CcSEcCtD
Naphazoline—Hypertension—Bupropion—obesity	0.000287	0.00508	CcSEcCtD
Naphazoline—Discomfort—Bupropion—obesity	0.000279	0.00495	CcSEcCtD
Naphazoline—Somnolence—Sibutramine—obesity	0.000276	0.00489	CcSEcCtD
Naphazoline—Hyperglycaemia—Topiramate—obesity	0.000274	0.00485	CcSEcCtD
Naphazoline—Propranolol—ADRB3—obesity	0.00027	0.0969	CrCbGaD
Naphazoline—Hyperhidrosis—Bupropion—obesity	0.000262	0.00464	CcSEcCtD
Naphazoline—ADRA2A—islet of Langerhans—obesity	0.000249	0.0412	CbGeAlD
Naphazoline—ADRA2C—adrenal cortex—obesity	0.000247	0.041	CbGeAlD
Naphazoline—Somnolence—Bupropion—obesity	0.000241	0.00427	CcSEcCtD
Naphazoline—ADRA1A—cardiovascular system—obesity	0.000237	0.0392	CbGeAlD
Naphazoline—Asthenia—Orlistat—obesity	0.000231	0.00408	CcSEcCtD
Naphazoline—Eye disorder—Topiramate—obesity	0.000227	0.00402	CcSEcCtD
Naphazoline—Duloxetine—HTR2C—obesity	0.000226	0.0812	CrCbGaD
Naphazoline—Asthenia—Sibutramine—obesity	0.000223	0.00395	CcSEcCtD
Naphazoline—Dizziness—Orlistat—obesity	0.000212	0.00376	CcSEcCtD
Naphazoline—Erythema—Topiramate—obesity	0.000212	0.00375	CcSEcCtD
Naphazoline—ADRA1A—adipose tissue—obesity	0.000209	0.0346	CbGeAlD
Naphazoline—Tension—Topiramate—obesity	0.000208	0.00368	CcSEcCtD
Naphazoline—Dizziness—Sibutramine—obesity	0.000206	0.00364	CcSEcCtD
Naphazoline—Nervousness—Topiramate—obesity	0.000206	0.00364	CcSEcCtD
Naphazoline—Headache—Orlistat—obesity	0.000201	0.00356	CcSEcCtD
Naphazoline—ADRA2C—pituitary gland—obesity	0.0002	0.0331	CbGeAlD
Naphazoline—Vision blurred—Topiramate—obesity	0.000199	0.00353	CcSEcCtD
Naphazoline—ADRA2C—adipose tissue—obesity	0.000199	0.033	CbGeAlD
Naphazoline—Headache—Sibutramine—obesity	0.000195	0.00345	CcSEcCtD
Naphazoline—Asthenia—Bupropion—obesity	0.000194	0.00344	CcSEcCtD
Naphazoline—Nausea—Orlistat—obesity	0.000191	0.00338	CcSEcCtD
Naphazoline—Duloxetine—SLC6A4—obesity	0.000187	0.0672	CrCbGaD
Naphazoline—ADRA1A—adrenal gland—obesity	0.000187	0.031	CbGeAlD
Naphazoline—Nausea—Sibutramine—obesity	0.000185	0.00327	CcSEcCtD
Naphazoline—Hypertension—Topiramate—obesity	0.000183	0.00323	CcSEcCtD
Naphazoline—Dizziness—Bupropion—obesity	0.000179	0.00317	CcSEcCtD
Naphazoline—ADRA2C—adrenal gland—obesity	0.000178	0.0296	CbGeAlD
Naphazoline—Discomfort—Topiramate—obesity	0.000178	0.00315	CcSEcCtD
Naphazoline—Headache—Bupropion—obesity	0.00017	0.00301	CcSEcCtD
Naphazoline—Hyperhidrosis—Topiramate—obesity	0.000167	0.00296	CcSEcCtD
Naphazoline—ADRA1A—endocrine gland—obesity	0.000162	0.0269	CbGeAlD
Naphazoline—Nausea—Bupropion—obesity	0.000161	0.00285	CcSEcCtD
Naphazoline—ADRA2A—pituitary gland—obesity	0.000159	0.0264	CbGeAlD
Naphazoline—ADRA2A—adipose tissue—obesity	0.000159	0.0263	CbGeAlD
Naphazoline—Somnolence—Topiramate—obesity	0.000154	0.00272	CcSEcCtD
Naphazoline—ADRA1A—liver—obesity	0.000146	0.0243	CbGeAlD
Naphazoline—Duloxetine—HTR2A—obesity	0.000144	0.0517	CrCbGaD
Naphazoline—ADRA2A—adrenal gland—obesity	0.000142	0.0236	CbGeAlD
Naphazoline—ADRA2C—liver—obesity	0.000139	0.0231	CbGeAlD
Naphazoline—Propranolol—HTR1B—obesity	0.000138	0.0495	CrCbGaD
Naphazoline—Asthenia—Topiramate—obesity	0.000124	0.00219	CcSEcCtD
Naphazoline—ADRA2A—endocrine gland—obesity	0.000123	0.0205	CbGeAlD
Naphazoline—Propranolol—ADRB1—obesity	0.000122	0.0438	CrCbGaD
Naphazoline—Dizziness—Topiramate—obesity	0.000114	0.00202	CcSEcCtD
Naphazoline—Headache—Topiramate—obesity	0.000108	0.00192	CcSEcCtD
Naphazoline—Nausea—Topiramate—obesity	0.000103	0.00182	CcSEcCtD
Naphazoline—Propranolol—ADRB2—obesity	0.000103	0.0368	CrCbGaD
Naphazoline—ADRA2C—Signaling Pathways—LPL—obesity	4.87e-06	6.64e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—obesity	4.85e-06	6.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAV1—obesity	4.84e-06	6.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SOCS1—obesity	4.84e-06	6.6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FOXO1—obesity	4.84e-06	6.6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RPS6KB1—obesity	4.83e-06	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOA1—obesity	4.83e-06	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—obesity	4.82e-06	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRL—obesity	4.81e-06	6.56e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCD—obesity	4.8e-06	6.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CD—obesity	4.79e-06	6.54e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CB—obesity	4.78e-06	6.52e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SOCS3—obesity	4.78e-06	6.52e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STK11—obesity	4.74e-06	6.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—LPL—obesity	4.73e-06	6.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—obesity	4.72e-06	6.44e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—obesity	4.7e-06	6.41e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—C3—obesity	4.7e-06	6.4e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLG—obesity	4.69e-06	6.39e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—RHOA—obesity	4.68e-06	6.38e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNB3—obesity	4.68e-06	6.38e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT2—obesity	4.64e-06	6.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3R1—obesity	4.63e-06	6.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GPX1—obesity	4.62e-06	6.3e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—TYK2—obesity	4.61e-06	6.29e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	4.6e-06	6.28e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF2—obesity	4.59e-06	6.27e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FOXO3—obesity	4.58e-06	6.24e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RHOA—obesity	4.57e-06	6.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—obesity	4.56e-06	6.22e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNAS—obesity	4.55e-06	6.21e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3R1—obesity	4.53e-06	6.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CD36—obesity	4.5e-06	6.13e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SOCS1—obesity	4.49e-06	6.13e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCD—obesity	4.49e-06	6.12e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS2—obesity	4.47e-06	6.09e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGT—obesity	4.46e-06	6.09e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOB—obesity	4.46e-06	6.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CD—obesity	4.45e-06	6.08e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT1—obesity	4.44e-06	6.06e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SOCS3—obesity	4.44e-06	6.05e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CG—obesity	4.41e-06	6.01e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—obesity	4.39e-06	5.99e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—C3—obesity	4.39e-06	5.98e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—obesity	4.37e-06	5.96e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—obesity	4.37e-06	5.96e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL5—obesity	4.35e-06	5.94e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNB3—obesity	4.35e-06	5.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CAV1—obesity	4.33e-06	5.91e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOA1—obesity	4.32e-06	5.89e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—TYK2—obesity	4.28e-06	5.84e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	4.28e-06	5.83e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF2—obesity	4.27e-06	5.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—obesity	4.26e-06	5.81e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LPL—obesity	4.26e-06	5.81e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—obesity	4.25e-06	5.8e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RHOA—obesity	4.25e-06	5.8e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNAS—obesity	4.23e-06	5.77e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FOXO1—obesity	4.23e-06	5.77e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RPS6KB1—obesity	4.22e-06	5.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3R1—obesity	4.21e-06	5.74e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—obesity	4.19e-06	5.72e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARA—obesity	4.18e-06	5.7e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CB—obesity	4.18e-06	5.7e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ESR1—obesity	4.17e-06	5.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS2—obesity	4.17e-06	5.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—INS—obesity	4.17e-06	5.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGT—obesity	4.17e-06	5.68e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—obesity	4.15e-06	5.66e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOB—obesity	4.14e-06	5.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PIK3CA—obesity	4.12e-06	5.63e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—F2—obesity	4.12e-06	5.62e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCB—obesity	4.12e-06	5.62e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—obesity	4.08e-06	5.57e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—obesity	4.08e-06	5.57e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—BAD—obesity	4.07e-06	5.56e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AGT—obesity	4.05e-06	5.52e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL5—obesity	4.05e-06	5.52e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CAV1—obesity	4.05e-06	5.52e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOA1—obesity	4.04e-06	5.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—obesity	3.97e-06	5.41e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LPL—obesity	3.96e-06	5.4e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CG—obesity	3.94e-06	5.38e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAV1—obesity	3.93e-06	5.36e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FOXO1—obesity	3.93e-06	5.36e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCD—obesity	3.92e-06	5.35e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RPS6KB1—obesity	3.92e-06	5.35e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOA1—obesity	3.92e-06	5.35e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS1—obesity	3.9e-06	5.32e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ESR1—obesity	3.9e-06	5.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CB—obesity	3.88e-06	5.3e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CD—obesity	3.87e-06	5.28e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—F2—obesity	3.85e-06	5.25e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCB—obesity	3.85e-06	5.25e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—obesity	3.84e-06	5.24e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—C3—obesity	3.83e-06	5.23e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—obesity	3.82e-06	5.22e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BAD—obesity	3.8e-06	5.19e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—obesity	3.76e-06	5.12e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INS—obesity	3.73e-06	5.09e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CG—obesity	3.68e-06	5.03e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—obesity	3.67e-06	5.01e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—obesity	3.66e-06	4.99e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3R1—obesity	3.66e-06	4.99e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS2—obesity	3.65e-06	4.98e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCD—obesity	3.65e-06	4.97e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGT—obesity	3.64e-06	4.97e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS1—obesity	3.64e-06	4.97e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—obesity	3.61e-06	4.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT2—obesity	3.61e-06	4.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CG—obesity	3.58e-06	4.88e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—obesity	3.57e-06	4.87e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—obesity	3.57e-06	4.87e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—obesity	3.57e-06	4.87e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—C3—obesity	3.56e-06	4.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CAV1—obesity	3.54e-06	4.82e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOA1—obesity	3.53e-06	4.81e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—obesity	3.51e-06	4.78e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INS—obesity	3.49e-06	4.76e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CD—obesity	3.47e-06	4.73e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—obesity	3.45e-06	4.71e-05	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	3.44e-06	4.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—obesity	3.43e-06	4.68e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—obesity	3.43e-06	4.68e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ESR1—obesity	3.41e-06	4.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—obesity	3.41e-06	4.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS2—obesity	3.39e-06	4.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—INS—obesity	3.39e-06	4.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGT—obesity	3.38e-06	4.62e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CB—obesity	3.38e-06	4.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—obesity	3.37e-06	4.6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT2—obesity	3.37e-06	4.6e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—obesity	3.37e-06	4.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCB—obesity	3.37e-06	4.59e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—F2—obesity	3.37e-06	4.59e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—obesity	3.35e-06	4.56e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TYK2—obesity	3.34e-06	4.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BAD—obesity	3.33e-06	4.54e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—obesity	3.32e-06	4.52e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—obesity	3.32e-06	4.52e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RHOA—obesity	3.31e-06	4.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CAV1—obesity	3.29e-06	4.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOA1—obesity	3.28e-06	4.47e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3R1—obesity	3.27e-06	4.47e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—obesity	3.27e-06	4.47e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CD—obesity	3.24e-06	4.42e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CG—obesity	3.22e-06	4.39e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	3.21e-06	4.38e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—obesity	3.2e-06	4.37e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS1—obesity	3.18e-06	4.34e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ESR1—obesity	3.17e-06	4.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CD—obesity	3.15e-06	4.29e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—F2—obesity	3.13e-06	4.27e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCB—obesity	3.13e-06	4.27e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CA—obesity	3.12e-06	4.25e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TYK2—obesity	3.12e-06	4.25e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—obesity	3.11e-06	4.24e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RHOA—obesity	3.09e-06	4.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BAD—obesity	3.09e-06	4.22e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—obesity	3.07e-06	4.18e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3R1—obesity	3.06e-06	4.17e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—obesity	3.06e-06	4.17e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INS—obesity	3.05e-06	4.16e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MTOR—obesity	3.02e-06	4.12e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CB—obesity	3.02e-06	4.12e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—obesity	3e-06	4.09e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CG—obesity	2.99e-06	4.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3R1—obesity	2.97e-06	4.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—obesity	2.97e-06	4.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS1—obesity	2.96e-06	4.04e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—obesity	2.95e-06	4.02e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT2—obesity	2.95e-06	4.02e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CA—obesity	2.91e-06	3.97e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—obesity	2.85e-06	3.89e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INS—obesity	2.83e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CD—obesity	2.83e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MTOR—obesity	2.82e-06	3.85e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CB—obesity	2.82e-06	3.85e-05	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—obesity	2.81e-06	3.83e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	2.8e-06	3.83e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—obesity	2.8e-06	3.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—obesity	2.79e-06	3.8e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—obesity	2.76e-06	3.77e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CB—obesity	2.74e-06	3.74e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—obesity	2.74e-06	3.74e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT2—obesity	2.74e-06	3.74e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TYK2—obesity	2.72e-06	3.72e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—obesity	2.72e-06	3.71e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RHOA—obesity	2.7e-06	3.69e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3R1—obesity	2.67e-06	3.65e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—obesity	2.67e-06	3.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CD—obesity	2.63e-06	3.59e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—obesity	2.63e-06	3.58e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—obesity	2.62e-06	3.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	2.61e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—obesity	2.6e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—obesity	2.58e-06	3.52e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK8—obesity	2.56e-06	3.49e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—obesity	2.55e-06	3.48e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CA—obesity	2.55e-06	3.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TYK2—obesity	2.53e-06	3.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RHOA—obesity	2.51e-06	3.42e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—obesity	2.48e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3R1—obesity	2.48e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MTOR—obesity	2.47e-06	3.37e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CB—obesity	2.47e-06	3.37e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—obesity	2.45e-06	3.35e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK8—obesity	2.39e-06	3.26e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—obesity	2.38e-06	3.25e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CA—obesity	2.37e-06	3.23e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—obesity	2.34e-06	3.19e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MTOR—obesity	2.29e-06	3.13e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CB—obesity	2.29e-06	3.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—obesity	2.29e-06	3.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—obesity	2.26e-06	3.08e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—obesity	2.18e-06	2.98e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—obesity	2.17e-06	2.96e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—obesity	2.17e-06	2.95e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—obesity	2.15e-06	2.93e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—obesity	2.13e-06	2.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—obesity	2.1e-06	2.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK8—obesity	2.09e-06	2.85e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—obesity	2.08e-06	2.84e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CA—obesity	2.06e-06	2.81e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—obesity	2.03e-06	2.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—obesity	2.02e-06	2.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—obesity	1.99e-06	2.72e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK8—obesity	1.94e-06	2.64e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—obesity	1.93e-06	2.64e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—obesity	1.91e-06	2.6e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CA—obesity	1.84e-06	2.51e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—obesity	1.77e-06	2.42e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—obesity	1.77e-06	2.42e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—obesity	1.77e-06	2.41e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CA—obesity	1.72e-06	2.35e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—obesity	1.68e-06	2.29e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CA—obesity	1.67e-06	2.28e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—obesity	1.65e-06	2.25e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—obesity	1.64e-06	2.24e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—obesity	1.63e-06	2.23e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—obesity	1.52e-06	2.08e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—obesity	1.51e-06	2.05e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CA—obesity	1.5e-06	2.05e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—obesity	1.41e-06	1.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.4e-06	1.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—obesity	1.37e-06	1.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—obesity	1.33e-06	1.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—obesity	1.24e-06	1.69e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—obesity	1.23e-06	1.68e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—obesity	1.14e-06	1.56e-05	CbGpPWpGaD
